Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/1999
10/28/1999WO1999054351A1 Edg family gene, human h218
10/28/1999WO1999054333A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/28/1999WO1999054329A1 Novel 2-heterocyclically substituted dihydropyrimidines
10/28/1999WO1999054326A1 Dihydropyrimidines
10/28/1999WO1999054312A1 The use of dihydropyrimidines as medicaments, and novel substances
10/28/1999WO1999054298A1 Method for producing enantiomer-free n-methyl-n- [(1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
10/28/1999WO1999054284A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999WO1999054280A1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
10/28/1999WO1999053951A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
10/28/1999WO1999053935A1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga
10/28/1999WO1999053893A1 Desensitizing dentifrice containing potassium and tin salts
10/28/1999WO1999004773A9 Method for inhibiting bone resorption
10/28/1999WO1997029739A3 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
10/28/1999CA2328876A1 Novel 2-heterocyclically substituted dihydropyrimidines
10/28/1999CA2328733A1 The use of dihydropyrimidines as medicaments, and novel substances
10/28/1999CA2328463A1 Matrix binding factor
10/28/1999CA2328413A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999CA2325871A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep
10/28/1999CA2325848A1 B-cell growth factor related protein
10/27/1999EP0952220A2 Method to predict active growth of bacteria adhered to a surface
10/27/1999EP0952154A2 N-acyl and N-aroyl aralkyl amides
10/27/1999EP0952149A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors
10/27/1999EP0951290A1 Absorbable composition containing propionic bacteria capable of releasing nitric oxide in the human or animal alimentary canal
10/27/1999EP0951282A1 Prevention and treatment of skeletal disorder with ep2 receptor subtype selective prostaglandin e2 agonists
10/27/1999EP0951278A2 Sustained release cisapride mini-tablet formulation
10/27/1999CN1233256A Dipeptide benzamidine as a kininogenase inhibitor
10/27/1999CN1233254A Purine L-nucleosides, analogs and uses thereof
10/27/1999CN1233238A Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
10/27/1999CN1233237A Heteroaryl succinamides and their use as metalloproteinase inhibitors
10/27/1999CN1233173A Therapeutic methods and compositions involving isoflavones
10/27/1999CN1232696A Health beverage capable of invigorating spleen and stomach
10/27/1999CN1232676A Chinese medicine for cholecystitis
10/27/1999CN1045964C Heterocyclic compounds and their preparation and use
10/27/1999CN1045955C Quinoline derivative and its producing process and its application and pharmaceutical composition containing the same derivative
10/26/1999US5973009 Antioxidant and cytoprotecting activity
10/26/1999US5972972 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
10/26/1999US5972965 4,5-diaryl oxazole derivatives
10/26/1999US5972961 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
10/26/1999US5972940 Arginine analogues having nitric oxide synthase inhibitor activity
10/26/1999US5972939 Cyclopentene derivatives useful as antagonists of the motilin receptor
10/26/1999US5972935 Psychological disordrs, nervous system disorders, parkinson's disorder
10/26/1999US5972897 Acylated enol derivatives as prodrugs of elastase inhibitors
10/26/1999US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999US5972894 Peptides having potassium channel opener activity
10/26/1999US5972698 Tryptase is expressed virtually exclusively by mast cells.
10/26/1999US5972688 HTm4 methods of treatment and assays, agonists and antagonists
10/26/1999CA2183320C Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
10/21/1999WO1999052932A1 Fatty acid derivatives of bile acids and bile acid derivatives
10/21/1999WO1999052927A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/21/1999WO1999052910A1 Bicyclic hydroxamic acid derivatives
10/21/1999WO1999052907A1 Azabicyclic 5ht1 receptor ligands
10/21/1999WO1999052903A1 Prodrugs of benzofuranylmethyl carbamate nk1 antagonists
10/21/1999WO1999052898A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
10/21/1999WO1999052889A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
10/21/1999WO1999052868A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
10/21/1999WO1999052862A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors
10/21/1999WO1999052548A2 Conjugate vaccines for the prevention of dental caries
10/21/1999WO1999052538A1 Composition containing a herbal medicinal substance and a pharmaceutical drug
10/21/1999WO1999052529A1 Antioxidant stabilizer system for pharmaceutical formulations
10/21/1999WO1999052524A1 Use of cannabinoids as anti-inflammatory agents
10/21/1999WO1999052514A2 Pharmaceutical composition and combination preparation for immunosuppressive therapy
10/21/1999WO1999052493A2 Compounds that inhibit the binding of integrins to their receptors
10/21/1999WO1999046245A3 PROCESSES FOR THE PREPARATION OF (R)-α- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
10/21/1999WO1999037623A3 Sulphonamide derivatives for treatment of cns disorders
10/21/1999DE19827633A1 Production of N-methyl-N-(1-phenyl-2-(3-hydroxypyrrolidino)ethyl)-2,2-diphenylacetamide enantiomers, e.g. with antiinflammatory, analgesic and diuretic activity
10/21/1999DE19817265A1 Treating hepatitis B using new or known dihydropyrimidine derivative antiviral agents
10/21/1999DE19817264A1 New dihydropyrimidine derivatives and their corresponding mesomers useful as antiviral agents
10/21/1999DE19817262A1 New dihydropyrimidine derivatives and their corresponding mesomers useful in treatment of hepatitis
10/21/1999CA2328211A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
10/21/1999CA2327782A1 Azabicyclic 5ht1 receptor ligands
10/21/1999CA2327708A1 Antioxidant stabilizer system for pharmaceutical formulations
10/21/1999CA2327431A1 Pharmaceutical composition
10/21/1999CA2325559A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/21/1999CA2325338A1 Conjugate vaccines for the prevention of dental caries
10/20/1999EP0950657A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors
10/20/1999EP0950417A2 Treatment of skeletal disorders
10/20/1999EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999EP0950059A1 Cyclic sulfone derivatives
10/20/1999EP0950058A1 Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists
10/20/1999EP0950047A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/20/1999EP0949917A1 Substances and their uses
10/20/1999EP0949899A1 Dentifrice compositions containing polyphosphate and fluoride
10/20/1999EP0740655B1 Metalloproteinase inhibitors
10/20/1999CN1232457A 1,4-heterocyclic metalloprotease inhibitors
10/20/1999CN1232451A Substd. cyclic amine metalloprotease inhibitors
10/20/1999CN1232399A Inhibitors of cysteine protease
10/20/1999CN1231916A Hepatitis restoration pill
10/20/1999CN1231910A Chinese patent medicine for treating gastrosis
10/20/1999CN1231901A Mongolia patent drug for treating peptic ulcer, and its producing method
10/20/1999CN1045777C Tetracyclic derivs. process of preparation and use
10/19/1999US5969184 Amide compounds
10/19/1999US5969120 Dna molecule with synthetically mutated retinoblastoma gene encoding a mutated protein; therapy for a tumor cell with mutation in cyclin gene; antitumor agents
10/19/1999US5969093 Secreted proteins
10/19/1999US5968950 Treatment of hypertriglyceridemia with decreasing apo b secretion for treatment of atheriosclerosis, pancreatitis, obesity or diabetes
10/19/1999US5968945 Immunotherapeutic agents
10/19/1999US5968923 (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/19/1999US5968903 Helicobacter and antigrowth agents, using somatostatin or agonist
10/19/1999US5968826 Antisense inhibition of integrin α4 expression
10/19/1999US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
10/19/1999US5968520 Plant extracts from alder and mountain ash; hangover remedy
1 ... 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 ... 1258